BEPBASO
Live / Registered — Registered (as of 15 Jul 2025)
What this means for you
Registered since 15 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97545159
- Registration number
- 7862917
- Mark type
- Stylized text
- Filed
- 11 Aug 2022
- Published for opposition
- 12 Mar 2024
- Registered
- 15 Jul 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 15 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 20 Jun 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 07 Nov 2024 — NOTICE OF ALLOWANCE CANCELLED
- 20 Jun 2025 — REVIEW OF CORRESPONDENCE COMPLETE
- 12 Jun 2025 — REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
- 09 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 05 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 07 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION
- 21 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER